This image was taken during a practical training exercise for the trachoma graders (diagnostic technicians) in a community just outside of Ouagadougou, Burkina Faso. Here, the technician was in the process of performing an outdoor examination of a womans right eye, looking for symptoms of trachoma, while the patient held her observant child in her lap.
Photographed by Centers for Disease Control and Prevention (CDC) ORISE Fellow, Alaine Kathryn Knipes, this image was one of three First Place winners in the 2014 CDC Connects Annual Public Health in Action Photo Contest, all submitted by Ms. Kathryn Knipes in the International People Category. CDC Connects is the organizations internally-published public health news site.
Trachoma, an eye disease caused by the bacterium Chlamydia trachomatis, affects approximately 84 million people worldwide. If left untreated it can lead to blindness. According to the World Health Organization (WHO), mass drug administration (MDA) with azithromycin is required to control trachoma. A study protocol was developed by the CDC, the Burkina Faso Ministry of Health, and the International trachoma initiative (ITI), aimed to concurrently monitor the impact of MDAs on schistosomiasis, soil-transmitted helminthes (STH), lymphatic filariasis (LF), and trachoma, over a three-year period. The study aimed to provide an easier, more cost-effective means of impact assessment. Burkina Faso was one of two countries to participate in the field-testing of this protocol.